好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

ASPIRE Interferon Beta 1-b in Combination with Azathioprine for Secondary Progressive Multiple Sclerosis: A 2-Years Double Blind, Randomized, Multicentre, Pilot Study. Safety and Drop-Outs Data at 21 Month of Enrollement.
MS and Related Diseases
(-)
099
Authors/Disclosures
Letizia Manneschi (Polichnico Le Scotte) No disclosure on file
Homa Ebrahimi, MD No disclosure on file
Ilaria Pesci (U.O.Neurologia Ospedale di Vaio Fidenza ( Par) No disclosure on file
Luca Durelli, MD (Divisione Universitaria di Neurologia) No disclosure on file
Luisa Motti (AZ. Osp Santa Maria Nuova) No disclosure on file
Elisa Merelli (Dompe' Biotec) No disclosure on file
Leandro Provinciali, MD (Istituto Malattie Sistema Nervoso) No disclosure on file
Vincenzo Brescia Morra, MD (Universita Federico II - Napoli) Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Elio A. Scarpini, MD (University of Milan) No disclosure on file
Domenico Caputo, MD (Fondazione Don Carlo Gnocchi) No disclosure on file
Maria R. Tola, MD (Azienda Ospedaliero-Universitaria di Ferrara) No disclosure on file
Maria G. Marrosu No disclosure on file
Angelo Ghezzi, MD No disclosure on file
Paola Cavalla No disclosure on file
Enrico Montanari (Ospedale Di Vaio) No disclosure on file